Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2026-01-02 @ 5:22 AM
Study NCT ID:
NCT06000657
Status:
COMPLETED
Last Update Posted:
2025-03-18
First Post:
2023-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir
Sponsor:
Daewoong Pharmaceutical Co. LTD.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-03
Completion Date Type:
ACTUAL
First Submit Date:
2023-07-16
First Submit QC Date:
None
Study First Post Date:
2023-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-17
Last Update Post Date:
2025-03-18
Last Update Post Date Type:
ACTUAL